Stock Details
PFE is Pfizer Inc.'s stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 48.68$. Average daily volumn in 3 months 22.14M. Market cap 246.87B



Stock symbol : PFE. Exchange : NYSE. Currency : USD
Lastest price : 43.98$. Total volume : 19.35M. Market state POST
Click reload if you want to check the lastest price on market!!!

Pfizer Inc. (PFE)
Last Price
43.98$
Change
0.39
Volume
19.35M

Previous Close43.59
Open43.55
Day Range43.53-44.10
Bid43.98 x 800
Ask44.02 x 2.9k
Volume19.35M
Average Volume22.14M
Market Cap246.87B
Beta0.58
52 Week Range41.45-56.32
Trailing P/E8.04
Foward P/E11.60
Dividend (Yield %)3.76%
Ex-Dividend Date2023-01-26



Financial Details


According to Pfizer Inc.'s financial reports the company's revenue in 2022 were 100.33B an decrease( +23.46%) over the years 2021 revenue that were of 81.29B. In 2022 the company's total earnings were 31.37B while total earnings in 2021 were 21.98B( +47.62%).


Loading ...



Organization

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 trea... tment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Market Cap:
246.87B
Revenue:
100.33B


News about "Pfizer Inc."

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Source from : Yahoo Finance - 1 days ago

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Shares ...See details»


pfizer-inc-nysepfe-q4-2022-earnings-call-transcript-image

Pfizer Inc. (NYSE:PFE) Q4 2022 Earnings Call Transcript

Source from : YAHOO!News - 7 days ago

Q4 2022 Earnings Call January 31, 2023 Operator: Good day, everyone, and welcome to Pfizerโ€™s Fourth Quarter 2022 Earnings Conference Call. Todayโ€™s call is being recorded. At this time, I would like to ...See details»


Pfizer Inc. (PFE) Could Be Worth Consideration Now, Even At A Loss Of -27.83% Since Its High Price

Source from : stocksregister - 4 days ago

Pfizer Inc. (NYSE:PFE) price on Friday, February 03, fall -0.63% below its previous dayโ€™s close as a downside momentum from buyers pushed the stockโ€™s value to $44.06. A look at the stockโ€™s price ...See details»


pfizer inc.

Source from : Fox Business - 6 days ago

Pfizer Inc and BioNTech's COVID vaccine was approved for use in children under 5 years old in June, and new studies have shown the vaccine to be 73.2% effective within that age group. Pfizer Inc ...See details»


Pfizer Can't Catch a Break, but Investors Can

Source from : Yahoo Finance - 8 days ago

Shares of Pfizer Inc. (NYSE:PFE) fell 15% in the month of January, ending the month on a low note with an earnings report that included a lackluster outlook for 2023. Following record revenue of $ ...See details»


Pfizer Inc BDR (PFIZ34)

Source from : Investing - 2 days ago

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...See details»


Pfizer Inc. Q4 Profit Increases, beats estimates

Source from : Business Insider - 8 days ago

(RTTNews) - Pfizer Inc. (PFE) released a profit for its fourth quarter that increased from the same period last year and beat the Street estimates. The company's earnings totaled $5.00 billion ...See details»


Drugmaker Pfizer starts low with 2023 earnings forecast

Source from : ABC News - 8 days ago

Shares of Pfizer Inc. climbed 14 cents to $43.69 Tuesday in midday trading while broader indexes also rose slightly.See details»


Client Profile: Pfizer Inc

Source from : OpenSecrets.org - 17 days ago

NOTE: Figures on this page are calculations by OpenSecrets based on data from the Senate Office of Public Records. Data for the most recent year was downloaded on January 23, 2023 and includes ...See details»


Pfizer: Don't Expect Another Record Year

Source from : Seeking Alpha - 27 days ago

Pfizer Inc. (NYSE:PFE) stock has underperformed the S&P 500 (SPX) (SPY) since forming its mid-December bull trap highs. It posted a decline of nearly 14% (in price-performance terms), compared to ...See details»


Pfizer: Q4 Earnings Snapshot

Source from : Associated Press - 8 days ago

Pfizer Inc. (PFE) on Tuesday reported fourth-quarter earnings of $5 billion. On a per-share basis, the New York-based company said it had profit of 87 cents. Earnings, adjusted for one-time gains and ...See details»


Pfizer Inc. (PFE) Q4 2022 Earnings Call Transcript

Source from : Seeking Alpha - 8 days ago

Good day, everyone, and welcome to Pfizerโ€™s Fourth Quarter 2022 Earnings Conference Call. Todayโ€™s call is being recorded. At this time, I would like to turn the call over to Mr. Chris Stevo ...See details»


Pfizer Inc.

Source from : Wall Street Journal - 2 years ago

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...See details»


Drugmaker Pfizer starts low with 2023 earnings forecast

Source from : SFGate - 8 days ago

Shares of Pfizer Inc. climbed 14 cents to $43.69 Tuesday in midday trading while broader indexes also rose slightly.See details»